Author:
Sabino Valentina,Cottone Pietro,Blasio Angelo,Iyer Malliga R,Steardo Luca,Rice Kenner C,Conti Bruno,Koob George F,Zorrilla Eric P
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference104 articles.
1. Ajmo Jr CT, Vernon DO, Collier L, Pennypacker KR, Cuevas J (2006). Sigma receptor activation reduces infarct size at 24 h after permanent middle cerebral artery occlusion in rats. Curr Neurovasc Res 3: 89–98.
2. Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, Anoal M et al (2000). Immunocytochemical localization of the sigma (1) receptor in the adult rat central nervous system. Neuroscience 97: 155–170.
3. Ault DT, Radeff JM, Werling LL (1998). Modulation of [3H] Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor. J Pharmacol Exp Ther 284: 553–560.
4. Ault DT, Werling LL (1999). Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors. Eur J Pharmacol 386: 145–153.
5. Aydar E, Palmer CP, Klyachko VA, Jackson MB (2002). The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34: 399–410.